FUNCTIONALIZED PHOSPHONATES AND CHROMENES
559
Diethyl 2-(Dimethoxyphosphoryl)-3-(4-hydroxy-2-oxo-2H-chromen-3-yl)
succinate (4b). White powder, mp 192–194 ◦C, 0.71 g, yield 80%. IR (KBr) (νmax/cm−1):
3242, 1725, 1738, 1746 cm−1. Anal. calcd for C19H23O10P (442.35): C, 51.59; H, 5.24.
Found: C, 51.48; H, 5.18%. 1H NMR (500 MHz, CDCl3): δ 1.34 (3 H, t, 3JHH 7.4 Hz, Me),
1.38 (3 H, t, 3JHH 7.5 Hz, Me), 3.04 (3 H, d 3JHP 11.6 Hz, MeO), 3.75 (3 H, d 3JHP 11.6 Hz,
MeO), 4.02 (1 H, dd 2JHP 21.2 Hz 3JHH 12.4 Hz, CH), 4.21 (2 H, q, 3JHH 7.5 Hz, CH2O),
4.27 (2 H, q, 3JHH 7.4 Hz, CH2O), 5.18 (1 H, dd 3JHH 12.0 Hz 3JHP 9.2 Hz, CH), 6.87–7.90
(4 H, m, 4 CH), 8.09 (1 H, s, OH). 13C NMR (125.7 MHz, CDCl3): δ 13.4 (Me), 14.2 (Me),
44.0 (CH), 48.8 (d 1JPC 135.4 Hz, CH), 51.7 (d 2JPC 8.5 Hz, MeO), 54.6 (d, 2JPC 8.5 Hz,
MeO), 61.7 (CH2O), 62.3 (CH2O), 114.7 (C), 122.5 (CH), 124.3 (C), 125.8 (CH), 127.5
(CH), 128.2 (C), 132.4 (CH), 149.1 (C), 164.3 (C O), 166.8 (d 2JPC 5.8 Hz, C O), 173.2
(d 3JPC 22.3 Hz, C O). 31P NMR (202 MHz, CDCl3): δ 17.8.
Dimethyl 2-(Diphenoxyphosphoryl)-3-(4-hydroxy-2-oxo-2H-chromen-3-
◦
yl) succinate (4c). Pale yellow crystals, mp 204–206 C, 0.77 g, yield 72%. IR (KBr)
(νmax/cm−1): 3238, 1730, 1738, 1745 cm−1. Anal. calcd for C27H23O10P (538.44): C,
60.23; H, 4.31. Found: C, 60.34; H, 4.42%. 1H NMR (500 MHz, CDCl3): δ 3.74 (3 H, s,
MeO), 3.87 (3 H, s, MeO), 4.12 (1 H, dd 2JHP 21.2 Hz 3JHH 12.2 Hz, CH), 5.23 (1 H, dd
3JHH 12.2 Hz 3JHP 9.2 Hz, CH), 7.14–7.96 (14 H, m, 14 CH), 8.05 (1 H, s, OH). 13C NMR
(125.7 MHz, CDCl3): δ 44.2 (CH), 49.5 (d 1JPC 135.8 Hz, CH), 52.0 (OMe), 52.8 (MeO),
3
3
3
121.2 (d, JCP 6.4 Hz, 2 CH), 122.3 (d, JPC 10.2 Hz, C), 123.0 (d, JPC 5.6 Hz, 2 CH),
124.6 (CH), 126.2 (CH), 127.4 (CH), 128.2 (CH), 128.8 (CH), 130.4 (m, 4 CH), 130.8
(CH), 132.4 (C), 132.7 (C), 148.6 (d 2JPC 9.5 Hz, C), 150.8 (m, 2 C), 163.5 (C O), 168.2
(d 2JPC 17.0 Hz, C O), 175.3 (C O).
Diethyl
2-(Diphenoxyphosphoryl)-3-(4-◦hydroxy-2-oxo-2H-chromen-3-
yl) succinate (4d). Yellow powder, mp 212–214 C, 0.76 g, yield 68%. IR (KBr)
(νmax/cm−1): 3242, 1738, 1745, 1752. Anal. calcd for C29H27O10P (566.49): C, 61.49; H,
4.80. Found: C, 61.57; H, 4.86%. 1H NMR (500 MHz, CDCl3): δ 1.36 (3 H, t, 3JHH 7.6 Hz,
Me), 1.42 (3 H, t, 3JHH 7.6 Hz, Me), 4.16 (1 H, dd 2JHP 21.5 Hz 3JHH 12.0 Hz, CH), 4.24 (2
H, q, 3JHH 7.6 Hz CH2O), 4.34 (2 H, q, 3JHH 7.6 Hz, CH2O), 5.27 (1 H, dd 3JHH 12.5 Hz
3JHP 9.6 Hz, CH), 7.16-8.04 (14 H, m, 14 CH), 8.10 (1 H, s, OH). 13C NMR (125.7 MHz,
1
CDCl3): δ 13.2 (Me), 13.8 (Me), 44.6 (CH), 50.2 (d JPC 136.4 Hz, CH), 61.2 (CH2O),
3
3
3
62.3 (CH2O), 121.5 (d, JCP 6.8 Hz, 2 CH), 122.7 (d, JPC 10.6 Hz, C), 123.4 (d, JPC
6.3 Hz, 2 CH), 125.4 (CH), 126.7 (CH), 128.2 (CH), 128.8 (CH), 129.3 (CH), 130.8 (m, 4
CH), 131.3 (CH), 132.9 (C), 133.5 (C), 149.2 (d 2JPC 10.4 Hz, C), 151.3 (m, 2 C), 164.2
(C O), 169.3 (d 2JPC 18.4 Hz, C O), 176.2 (C O).
General Procedure for Preparation of Compounds 10a–b
To a magnetically stirred solution of dialkyl acethylenedicarboxylate 2 (2 mmol) and
4-hydroxycumarin 1 (2 mmol) in water was added triethyl phosphite 9 (2 mmol) slowly. The
reaction mixture was then stirred for 5 h at 70 ◦C. After completion of reaction (monitored
by TLC), the resulting precipitate was separated by filtration and recrystallized from EtOH
to afford the pure title compounds.
Methyl 2,5-Dioxo-3,4-dihydro-2H, 5H-pyrano[3,2-c]chromene-4-carboxy-
◦
late (10a). White powder, mp 130–132 C, 0.48 g, yield 87%., IR (KBr) (νmax/cm−1):
1735, 1757, 1463 cm−1. Anal. calcd for C14H10O6 (274.23): C, 61.32; H, 3.68. Found: C,
61.44; H, 3.76%. 1H NMR (500 MHz, CDCl3): δ 3.02 (1 H, dd 2JHH 15.8 Hz 3JHH 7.4 Hz,
HCH), 3.28 (1 H, dd 2JHH 15.8 Hz 3JHH 2.8 Hz, HCH), 3.78 (3 H, s, MeO), 4.12 (1 H, dd
3JHH 7.4 Hz 3JHH 2.8 Hz, CH), 7.28-7.76 (4 H, m, 4 CH). 13C NMR (125.7 MHz, CDCl3):